Pregnant vulva eczema nursing drug and preparation method thereof

Abstract

The invention discloses a pregnant vulva eczema nursing drug and a preparation method thereof. The pregnant vulva eczema nursing drug mainly comprises, by weight, 1-7 parts of cobamamide, 1-5 parts of fusidic acid, 0.2-1 part of a leukotriene receptor antagonist, 2.2-5 parts of acetylshikonin, 1.2-1.6 parts of calcipotriol, 0.3-3.5 parts of uronic acid, 0.7-2.5 parts of sulfonate mucopolysaccharide, 0.8-2.4 parts of betaine, 1.2-4 parts of allantoin, 1-6 parts of cetostearyl alcohol, 1-2.5 parts of jojoba oil, 0.03-0.2 parts of salicylic acid, 0.2-0.5 parts of lysozyme, 0.1-0.3 parts of ceramide, 0.1-3 parts of terpineol, 0.02-0.1 parts of an emulsifier and 0.01-0.1 parts of an antiseptic. The pregnant vulva eczema nursing drug is a composition formed by various components, is prepared through long-term massive experiments by the inventor, has stable and definite drug effects and high safety, and is especially suitable for treating pregnant vulva eczemas.

Description

technical field [0001] The invention relates to the technical field of medical care, in particular to a medicine for treating vulva eczema during pregnancy and a preparation method thereof. Background technique [0002] Vulvar eczema is a common non-infectious skin disease. The lesions are mostly limited to the perineum and clitoris, and occasionally spread to the buttocks. Local rashes, erythema, erosions, oozing, scabs, and desquamation may appear, and the course of the disease is long. The skin around the perineum is often thickened, grayish-white or dark red, rough, so that chapping, exudation, itching, and recurrent attacks are the main features, and the disease can occur at any age. From the perspective of pathogenesis, vulvar eczema is mainly a delayed allergic reaction caused by complex internal and external stimulating factors. However, whether its etiology is related to the nature of the allergen, the characteristics of the immune response, and whether it is relat...

AI Technical Summary

Problems solved by technology

Therefore, unlike other allergic eczemas, eczema lesions during pregnancy will not disappear quickly even if some sensitizing factors are removed. In addition, the principle of safety first must be followed when taking medicines during pregnancy. Although the efficacy of traditional Chinese medicine is relatively mild, the existing Various traditional Chinese medicine care agents have the problem of inaccurate efficacy, so the existing eczema care medicines are not suitable for the treatment of vulvar eczema during pregnancy